scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PNAS..11118679G |
P356 | DOI | 10.1073/PNAS.1422050112 |
P932 | PMC publication ID | 4284555 |
P698 | PubMed publication ID | 25512507 |
P5875 | ResearchGate publication ID | 273956724 |
P50 | author | Clara D. Bloomfield | Q4793409 |
Carlo Maria Croce | Q640381 | ||
James S Blachly | Q55445072 | ||
Guido Marcucci | Q66370794 | ||
Krzysztof Mrózek | Q66385542 | ||
Jessica Kohlschmidt | Q66411780 | ||
John C. Byrd | Q66429603 | ||
Pearlly Yan | Q89625737 | ||
Jonathan E Kolitz | Q90696849 | ||
Meir Wetzler | Q96067562 | ||
Michael A Caligiuri | Q97333782 | ||
William G Blum | Q98243202 | ||
Deedra Rae Nicolet | Q110818080 | ||
Ramiro Garzon | Q114413063 | ||
Donna Bucci | Q114413077 | ||
Bayard L Powell | Q114413078 | ||
Stefano Volinia | Q28324641 | ||
Thomas Carter | Q40548426 | ||
Ann-Kathrin Eisfeld | Q43376244 | ||
P2093 | author name string | Richard M Stone | |
Andrew J Carroll | |||
Maria R Baer | |||
Joseph O Moore | |||
Dimitrios Papaioannou | |||
P2860 | cites work | Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 |
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression | Q24608592 | ||
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin | Q24652323 | ||
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia | Q24655915 | ||
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster | Q24657435 | ||
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs | Q24673619 | ||
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia | Q27851430 | ||
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group | Q27851459 | ||
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. | Q27851460 | ||
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study | Q27851545 | ||
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study | Q27851621 | ||
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category | Q27851679 | ||
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia | Q27851713 | ||
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures | Q27851839 | ||
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study | Q73292530 | ||
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome | Q82366072 | ||
Wilms' tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia | Q83304136 | ||
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Q29012757 | ||
RNA maps reveal new RNA classes and a possible function for pervasive transcription | Q29614334 | ||
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer | Q29620125 | ||
A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins | Q30413762 | ||
Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study | Q34310561 | ||
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study | Q34541748 | ||
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. | Q34569095 | ||
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. | Q34696246 | ||
MicroRNA expression in cytogenetically normal acute myeloid leukemia | Q34775265 | ||
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia | Q35152173 | ||
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? | Q35615901 | ||
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia | Q35794120 | ||
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. | Q35849784 | ||
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia | Q36100455 | ||
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. | Q36357062 | ||
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience | Q36713551 | ||
Acute myeloid leukemia and myelodysplastic syndromes in older patients | Q36815566 | ||
Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer | Q37001515 | ||
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients | Q37065843 | ||
lincRNAs: genomics, evolution, and mechanisms | Q37584905 | ||
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance | Q38321981 | ||
Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis | Q39044266 | ||
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers | Q39066542 | ||
Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer | Q39350395 | ||
Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression | Q39404230 | ||
Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer | Q40189832 | ||
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. | Q40322576 | ||
Vaults are up-regulated in multidrug-resistant cancer cell lines | Q44110027 | ||
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. | Q51856604 | ||
Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. | Q52182053 | ||
P433 | issue | 52 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 18679-18684 | |
P577 | publication date | 2014-12-15 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Expression and prognostic impact of lncRNAs in acute myeloid leukemia | |
P478 | volume | 111 |
Q91669258 | A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia |
Q89777231 | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes |
Q100407536 | A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis |
Q64082752 | A critical regulator of Bcl2 revealed by systematic transcript discovery of lncRNAs associated with T-cell differentiation |
Q38695117 | A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. |
Q38882922 | A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival |
Q89100184 | A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients |
Q94526828 | Aberrant LncRNA Expression in Leukemia |
Q31147507 | Acfs: accurate circRNA identification and quantification from RNA-Seq data |
Q39400164 | Acute myeloid leukaemia genomics. |
Q52431745 | An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. |
Q35731376 | An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies. |
Q38804181 | Annotating Function to Differentially Expressed LincRNAs in Myelodysplastic Syndrome Using a Network-Based Method |
Q30490446 | Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia |
Q36210927 | C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia |
Q37089402 | Chimeric mitochondrial peptides from contiguous regular and swinger RNA. |
Q91883638 | Circular RNAs in leukemia |
Q47134666 | Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia |
Q26749533 | Clinical significance of microRNAs in chronic and acute human leukemia |
Q37628972 | Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma |
Q36000584 | Differential Expression of Long Noncoding RNAs between Sperm Samples from Diabetic and Non-Diabetic Mice |
Q49856822 | Differentially expressed host long intergenic noncoding RNA and mRNA in HIV-1 and HIV-2 infection. |
Q92435023 | Emerging role of long non-coding RNAs in normal and malignant hematopoiesis |
Q94475911 | Epigenetic landscape analysis of lncRNAs in acute myeloid leukemia with DNMT3A mutations |
Q37721277 | Evolution of Nucleotide Punctuation Marks: From Structural to Linear Signals |
Q92284294 | Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells |
Q55365672 | Expression levels of long non-coding RNAs are prognostic for AML outcome. |
Q30275293 | Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis |
Q47343750 | Expression profile analysis of long noncoding RNA in Acute Myeloid Leukemia by microarray and bioinformatics. |
Q89238692 | Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation |
Q53190281 | Genome-wide characterization of lncRNAs in acute myeloid leukemia. |
Q38697273 | High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia. |
Q64261228 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients |
Q28821250 | Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia |
Q36309654 | Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications |
Q90341915 | LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia |
Q36018337 | LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia |
Q37501589 | Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57. |
Q89113096 | Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis |
Q64275121 | Long Non-Coding RNA and Acute Leukemia |
Q38450930 | Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia |
Q90403271 | Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia |
Q92060295 | Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221 |
Q95267274 | Long Noncoding RNA H19 Facilitates Small Cell Lung Cancer Tumorigenesis Through miR-140-5p/FGF9 Axis |
Q53219055 | Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. |
Q53636125 | Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. |
Q38874356 | Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia |
Q92993245 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome |
Q37588369 | Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. |
Q90729138 | Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia |
Q60909314 | Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia |
Q64922153 | Long non-coding RNAs in hematopoietic regulation. |
Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
Q42341694 | Long non-coding RNAs: another brick in the wall of normal karyotype acute myeloid leukemia? |
Q38766067 | Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b |
Q64929485 | Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia. |
Q35895721 | Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection |
Q38698012 | Long noncoding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients |
Q46191604 | Long noncoding RNAs in hematopoietic malignancies |
Q28077492 | Long noncoding RNAs: pivotal regulators in acute myeloid leukemia |
Q38434466 | Microarray profiling and co-expression network analysis of the lncRNAs and mRNAs associated with acute leukemia in adults. |
Q58573068 | Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate |
Q92996721 | Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies |
Q36261877 | Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer |
Q36771874 | Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia |
Q64929300 | Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia. |
Q41018434 | Overexpression of long non-coding RNA zinc finger antisense 1 in acute myeloid leukemia cell lines influences cell growth and apoptosis |
Q92133424 | Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway |
Q36259132 | Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. |
Q38428692 | Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics. |
Q58781904 | Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics |
Q42396879 | Potential role of lncRNA cyp2c91-protein interactions on diseases of the immune system. |
Q58742926 | Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network |
Q92524019 | Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia |
Q38377189 | Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia |
Q38769960 | Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia |
Q28069144 | Prognostic value of RDW in cancers: a systematic review and meta-analysis |
Q97644946 | Rapid preliminary purity evaluation of tumor biopsies using deep learning approach |
Q61810422 | Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia |
Q64284722 | Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia |
Q92519522 | Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics |
Q89966216 | Systematic Nucleotide Exchange Analysis of ESTs From the Human Cancer Genome Project Report: Origins of 347 Unknown ESTs Indicate Putative Transcription of Non-Coding Genomic Regions |
Q90293326 | The Nefarious Nexus of Noncoding RNAs in Cancer |
Q58694197 | The Network of Non-coding RNAs in Cancer Drug Resistance |
Q92137481 | The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia |
Q50129316 | The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis. |
Q38972951 | The crosstalk between long non-coding RNAs and PI3K in cancer |
Q90352863 | The emergence of long non-coding RNAs in hepatocellular carcinoma: an update |
Q36544646 | The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. |
Q37633708 | The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway |
Q91451568 | The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia |
Q57093529 | The long non-coding RNA landscape in juvenile myelomonocytic leukemia |
Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
Q28071427 | Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs |
Q92337654 | Transcriptional networks in acute myeloid leukemia |
Q41910504 | Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation |
Q64907849 | Transcripts with systematic nucleotide deletion of 1-12 nucleotide in human mitochondrion suggest potential non-canonical transcription. |
Q28596502 | Unbiased Mitoproteome Analyses Confirm Non-canonical RNA, Expanded Codon Translations |
Q92459714 | circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression |
Q90350387 | lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1 |
Q47375547 | microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview |
Search more.